カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のリノテカン市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global lrinotecan Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7916）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7916
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のリノテカン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のリノテカンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のリノテカン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- リノテカンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

リノテカン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・イリノテカン塩酸塩注射液40mg、イリノテカン塩酸塩注射液100mg、その他

用途別セグメント
・診療所、病院、その他

主要な市場プレーヤー
・West-ward Pharmaceuticals、Pfizer、Teva、Actiza Pharmaceutical、Getwell、Taj Pharma、Cipla、Salius

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、リノテカン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なリノテカンメーカーの企業概要、2019年～2022年までのリノテカンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なリノテカンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別リノテカンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのリノテカンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのリノテカン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびリノテカンの産業チェーンを掲載しています。
・第14、15章では、リノテカンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– リノテカンの概要
– タイプ別分析（2018年vs2022年vs2029年）：イリノテカン塩酸塩注射液40mg、イリノテカン塩酸塩注射液100mg、その他
– 用途別分析（2018年vs2022年vs2029年）：診療所、病院、その他
– 世界のリノテカン市場規模・予測
– 世界のリノテカン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– West-ward Pharmaceuticals、Pfizer、Teva、Actiza Pharmaceutical、Getwell、Taj Pharma、Cipla、Salius
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：イリノテカン塩酸塩注射液40mg、イリノテカン塩酸塩注射液100mg、その他
・用途別分析2018年-2029年：診療所、病院、その他
・リノテカンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・リノテカンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・リノテカンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・リノテカンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・リノテカンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of lrinotecan
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global lrinotecan Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Irinotecan Hydrochloride Injection 40mg
1.3.3 Irinotecan Hydrochloride Injection 100mg
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global lrinotecan Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global lrinotecan Market Size & Forecast
1.5.1 Global lrinotecan Consumption Value (2018 & 2022 & 2029)
1.5.2 Global lrinotecan Sales Quantity (2018-2029)
1.5.3 Global lrinotecan Average Price (2018-2029)
2 Manufacturers Profiles
2.1 West-ward Pharmaceuticals
2.1.1 West-ward Pharmaceuticals Details
2.1.2 West-ward Pharmaceuticals Major Business
2.1.3 West-ward Pharmaceuticals lrinotecan Product and Services
2.1.4 West-ward Pharmaceuticals lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 West-ward Pharmaceuticals Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer lrinotecan Product and Services
2.2.4 Pfizer lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva lrinotecan Product and Services
2.3.4 Teva lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 Actiza Pharmaceutical
2.4.1 Actiza Pharmaceutical Details
2.4.2 Actiza Pharmaceutical Major Business
2.4.3 Actiza Pharmaceutical lrinotecan Product and Services
2.4.4 Actiza Pharmaceutical lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Actiza Pharmaceutical Recent Developments/Updates
2.5 Getwell
2.5.1 Getwell Details
2.5.2 Getwell Major Business
2.5.3 Getwell lrinotecan Product and Services
2.5.4 Getwell lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Getwell Recent Developments/Updates
2.6 Taj Pharma
2.6.1 Taj Pharma Details
2.6.2 Taj Pharma Major Business
2.6.3 Taj Pharma lrinotecan Product and Services
2.6.4 Taj Pharma lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Taj Pharma Recent Developments/Updates
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla lrinotecan Product and Services
2.7.4 Cipla lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cipla Recent Developments/Updates
2.8 Salius
2.8.1 Salius Details
2.8.2 Salius Major Business
2.8.3 Salius lrinotecan Product and Services
2.8.4 Salius lrinotecan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Salius Recent Developments/Updates
3 Competitive Environment: lrinotecan by Manufacturer
3.1 Global lrinotecan Sales Quantity by Manufacturer (2018-2023)
3.2 Global lrinotecan Revenue by Manufacturer (2018-2023)
3.3 Global lrinotecan Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of lrinotecan by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 lrinotecan Manufacturer Market Share in 2022
3.4.2 Top 6 lrinotecan Manufacturer Market Share in 2022
3.5 lrinotecan Market: Overall Company Footprint Analysis
3.5.1 lrinotecan Market: Region Footprint
3.5.2 lrinotecan Market: Company Product Type Footprint
3.5.3 lrinotecan Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global lrinotecan Market Size by Region
4.1.1 Global lrinotecan Sales Quantity by Region (2018-2029)
4.1.2 Global lrinotecan Consumption Value by Region (2018-2029)
4.1.3 Global lrinotecan Average Price by Region (2018-2029)
4.2 North America lrinotecan Consumption Value (2018-2029)
4.3 Europe lrinotecan Consumption Value (2018-2029)
4.4 Asia-Pacific lrinotecan Consumption Value (2018-2029)
4.5 South America lrinotecan Consumption Value (2018-2029)
4.6 Middle East and Africa lrinotecan Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global lrinotecan Sales Quantity by Type (2018-2029)
5.2 Global lrinotecan Consumption Value by Type (2018-2029)
5.3 Global lrinotecan Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global lrinotecan Sales Quantity by Application (2018-2029)
6.2 Global lrinotecan Consumption Value by Application (2018-2029)
6.3 Global lrinotecan Average Price by Application (2018-2029)
7 North America
7.1 North America lrinotecan Sales Quantity by Type (2018-2029)
7.2 North America lrinotecan Sales Quantity by Application (2018-2029)
7.3 North America lrinotecan Market Size by Country
7.3.1 North America lrinotecan Sales Quantity by Country (2018-2029)
7.3.2 North America lrinotecan Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe lrinotecan Sales Quantity by Type (2018-2029)
8.2 Europe lrinotecan Sales Quantity by Application (2018-2029)
8.3 Europe lrinotecan Market Size by Country
8.3.1 Europe lrinotecan Sales Quantity by Country (2018-2029)
8.3.2 Europe lrinotecan Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific lrinotecan Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific lrinotecan Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific lrinotecan Market Size by Region
9.3.1 Asia-Pacific lrinotecan Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific lrinotecan Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America lrinotecan Sales Quantity by Type (2018-2029)
10.2 South America lrinotecan Sales Quantity by Application (2018-2029)
10.3 South America lrinotecan Market Size by Country
10.3.1 South America lrinotecan Sales Quantity by Country (2018-2029)
10.3.2 South America lrinotecan Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa lrinotecan Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa lrinotecan Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa lrinotecan Market Size by Country
11.3.1 Middle East & Africa lrinotecan Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa lrinotecan Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 lrinotecan Market Drivers
12.2 lrinotecan Market Restraints
12.3 lrinotecan Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of lrinotecan and Key Manufacturers
13.2 Manufacturing Costs Percentage of lrinotecan
13.3 lrinotecan Production Process
13.4 lrinotecan Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 lrinotecan Typical Distributors
14.3 lrinotecan Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global lrinotecan Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global lrinotecan Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. West-ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. West-ward Pharmaceuticals Major Business
Table 5. West-ward Pharmaceuticals lrinotecan Product and Services
Table 6. West-ward Pharmaceuticals lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. West-ward Pharmaceuticals Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer lrinotecan Product and Services
Table 11. Pfizer lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva lrinotecan Product and Services
Table 16. Teva lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Actiza Pharmaceutical Major Business
Table 20. Actiza Pharmaceutical lrinotecan Product and Services
Table 21. Actiza Pharmaceutical lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Actiza Pharmaceutical Recent Developments/Updates
Table 23. Getwell Basic Information, Manufacturing Base and Competitors
Table 24. Getwell Major Business
Table 25. Getwell lrinotecan Product and Services
Table 26. Getwell lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Getwell Recent Developments/Updates
Table 28. Taj Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Taj Pharma Major Business
Table 30. Taj Pharma lrinotecan Product and Services
Table 31. Taj Pharma lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Taj Pharma Recent Developments/Updates
Table 33. Cipla Basic Information, Manufacturing Base and Competitors
Table 34. Cipla Major Business
Table 35. Cipla lrinotecan Product and Services
Table 36. Cipla lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cipla Recent Developments/Updates
Table 38. Salius Basic Information, Manufacturing Base and Competitors
Table 39. Salius Major Business
Table 40. Salius lrinotecan Product and Services
Table 41. Salius lrinotecan Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Salius Recent Developments/Updates
Table 43. Global lrinotecan Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global lrinotecan Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global lrinotecan Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in lrinotecan, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and lrinotecan Production Site of Key Manufacturer
Table 48. lrinotecan Market: Company Product Type Footprint
Table 49. lrinotecan Market: Company Product Application Footprint
Table 50. lrinotecan New Market Entrants and Barriers to Market Entry
Table 51. lrinotecan Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global lrinotecan Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global lrinotecan Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global lrinotecan Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global lrinotecan Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global lrinotecan Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global lrinotecan Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global lrinotecan Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global lrinotecan Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global lrinotecan Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global lrinotecan Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global lrinotecan Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global lrinotecan Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global lrinotecan Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global lrinotecan Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global lrinotecan Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global lrinotecan Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global lrinotecan Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global lrinotecan Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America lrinotecan Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America lrinotecan Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America lrinotecan Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America lrinotecan Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America lrinotecan Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America lrinotecan Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America lrinotecan Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America lrinotecan Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe lrinotecan Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe lrinotecan Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe lrinotecan Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe lrinotecan Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe lrinotecan Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe lrinotecan Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe lrinotecan Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe lrinotecan Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific lrinotecan Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific lrinotecan Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific lrinotecan Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific lrinotecan Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific lrinotecan Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific lrinotecan Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific lrinotecan Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific lrinotecan Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America lrinotecan Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America lrinotecan Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America lrinotecan Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America lrinotecan Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America lrinotecan Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America lrinotecan Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America lrinotecan Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America lrinotecan Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa lrinotecan Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa lrinotecan Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa lrinotecan Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa lrinotecan Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa lrinotecan Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa lrinotecan Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa lrinotecan Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa lrinotecan Consumption Value by Region (2024-2029) & (USD Million)
Table 110. lrinotecan Raw Material
Table 111. Key Manufacturers of lrinotecan Raw Materials
Table 112. lrinotecan Typical Distributors
Table 113. lrinotecan Typical Customers
List of Figures
Figure 1. lrinotecan Picture
Figure 2. Global lrinotecan Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global lrinotecan Consumption Value Market Share by Type in 2022
Figure 4. Irinotecan Hydrochloride Injection 40mg Examples
Figure 5. Irinotecan Hydrochloride Injection 100mg Examples
Figure 6. Others Examples
Figure 7. Global lrinotecan Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global lrinotecan Consumption Value Market Share by Application in 2022
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global lrinotecan Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global lrinotecan Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global lrinotecan Sales Quantity (2018-2029) & (K Units)
Figure 15. Global lrinotecan Average Price (2018-2029) & (US$/Unit)
Figure 16. Global lrinotecan Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global lrinotecan Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of lrinotecan by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 lrinotecan Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 lrinotecan Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global lrinotecan Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global lrinotecan Consumption Value Market Share by Region (2018-2029)
Figure 23. North America lrinotecan Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe lrinotecan Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific lrinotecan Consumption Value (2018-2029) & (USD Million)
Figure 26. South America lrinotecan Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa lrinotecan Consumption Value (2018-2029) & (USD Million)
Figure 28. Global lrinotecan Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global lrinotecan Consumption Value Market Share by Type (2018-2029)
Figure 30. Global lrinotecan Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global lrinotecan Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global lrinotecan Consumption Value Market Share by Application (2018-2029)
Figure 33. Global lrinotecan Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America lrinotecan Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America lrinotecan Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America lrinotecan Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America lrinotecan Consumption Value Market Share by Country (2018-2029)
Figure 38. United States lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe lrinotecan Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe lrinotecan Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe lrinotecan Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe lrinotecan Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific lrinotecan Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific lrinotecan Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific lrinotecan Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific lrinotecan Consumption Value Market Share by Region (2018-2029)
Figure 54. China lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America lrinotecan Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America lrinotecan Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America lrinotecan Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America lrinotecan Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa lrinotecan Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa lrinotecan Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa lrinotecan Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa lrinotecan Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa lrinotecan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. lrinotecan Market Drivers
Figure 75. lrinotecan Market Restraints
Figure 76. lrinotecan Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of lrinotecan in 2022
Figure 79. Manufacturing Process Analysis of lrinotecan
Figure 80. lrinotecan Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアスピリンビタミンC発泡性市場2023年：企業・地域・タイプ・用途別分析
  • 世界のメチルプレドニゾロン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の自動ABR市場2023年：企業・地域・タイプ・用途別分析
  • 世界のチロゲン&バイオシミラー市場2023年：企業・地域・タイプ・用途別分析
  • 世界のアバスチンバイオシミラー市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7916 )"世界のリノテカン市場2023年：企業・地域・タイプ・用途別分析" (英文：Global lrinotecan Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。